Reality orientation therapy has been assoReality orientation therapy has been associated with significant improvements in ciated with significant improvements in cognition and behaviour and with a cognition and behaviour and with a reduced risk of admission to care among reduced risk of admission to care among people with Alzheimer's disease (Zanetti people with Alzheimer's disease (Zanetti et al et al, 1995; Metitieri , 1995; Metitieri et al et al, 2001; Spector , 2001; Spector et al et al, 2003) . A meta-analysis of six con-, 2003) . A meta-analysis of six controlled trials concluded that reality orientatrolled trials concluded that reality orientation should be considered as part of tion should be considered as part of dementia care programmes, but also identidementia care programmes, but also identified the need for large, well-designed multified the need for large, well-designed multicentre trials (Spector centre trials (Spector et al et al, 2000 (Spector et al et al, , 2000a . In addi-). In addition, clinical trials of reality orientation tion, clinical trials of reality orientation published so far have not tested the effecpublished so far have not tested the effectiveness of this therapy in association with tiveness of this therapy in association with medication with cholinesterase inhibitors, medication with cholinesterase inhibitors, nor evaluated the efficacy of programmes nor evaluated the efficacy of programmes provided in the patient's own home provided in the patient's own home (Spector (Spector et al et al, 2000 (Spector et al et al, , 2000b . Therefore, the aim ). Therefore, the aim of this randomised clinical trial was to of this randomised clinical trial was to evaluate the effectiveness of a long-term evaluate the effectiveness of a long-term (25 weeks), home-based programme of (25 weeks), home-based programme of reality orientation on cognitive function in reality orientation on cognitive function in a group of patients with Alzheimer's disa group of patients with Alzheimer's disease receiving treatment with cholinesterase ease receiving treatment with cholinesterase inhibitors. inhibitors.
METHOD METHOD
The study was conducted in five Alzheimer The study was conducted in five Alzheimer Evaluation Units (Catholic University of the Evaluation Units (Catholic University of the Sacred Heart, Rome; Instituto di Ricovero e Sacred Heart, Rome; Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Centro Cura a Carattere Scientifico (IRCCS) Centro San Giovanni di Dio, Fatebenefratelli, San Giovanni di Dio, Fatebenefratelli, Brescia; Hospital San Eugenio, Rome; Brescia; Hospital San Eugenio, Rome; Hospital Opera Don Uva, Guidonia; Hospital Opera Don Uva, Guidonia; Hospital San Giovanni Calibita FatebeneHospital San Giovanni Calibita Fatebenefratelli, Rome) participating in the fratelli, Rome) participating in the CRONOS project, a national study spon-CRONOS project, a national study sponsored by the Italian government with the sored by the Italian government with the intention of standardising prescriptions of intention of standardising prescriptions of cholinesterase inhibitors and assessing the cholinesterase inhibitors and assessing the effects of these drugs on defined outcomes effects of these drugs on defined outcomes in unselected individuals with Alzheimer's in unselected individuals with Alzheimer's disease (Blanchetti disease (Blanchetti et al et al, 2003) . , 2003). People were considered suitable for People were considered suitable for participation in the study if they met the participation in the study if they met the , 1975) , did not present with major aphasia 1975), did not present with major aphasia or blindness, and had received pharmacoor blindness, and had received pharmacological treatment with donepezil for at least logical treatment with donepezil for at least 3 months. Figure 1 shows the trial profile, 3 months. Figure 1 shows the trial profile, including data on people screened and exincluding data on people screened and excluded because they did not meet the eligcluded because they did not meet the eligibility criteria. Data on those not receiving ibility criteria. Data on those not receiving pharmacological treatment with donepezil pharmacological treatment with donepezil for at least 3 months were not collected. for at least 3 months were not collected. All patients participating in the CRONOS All patients participating in the CRONOS project were taking donepezil (the only project were taking donepezil (the only cholinesterase inhibitor available in Italy cholinesterase inhibitor available in Italy at the time of the study) and were followed at the time of the study) and were followed for at least 6 months. for at least 6 months.
A total of 156 eligible patients, enrolled A total of 156 eligible patients, enrolled in the participating centres between January in the participating centres between January 2002 and August 2002, were randomly 2002 and August 2002, were randomly assigned in a 1:1 ratio to receive either a assigned in a 1:1 ratio to receive either a reality orientation programme at home, reality orientation programme at home, provided by caregivers, or no treatment. provided by caregivers, or no treatment. Participants were allocated to the two study Participants were allocated to the two study groups according to a computerised block groups according to a computerised block randomisation process (block randomisrandomisation process (block randomisation was used in order to keep the number ation was used in order to keep the number of participants in the different groups of participants in the different groups closely balanced at all times). closely balanced at all times).
Patients and caregivers participating in Patients and caregivers participating in the study were assessed at baseline and at the study were assessed at baseline and at the 25-week follow-up (end of the study) the 25-week follow-up (end of the study) by personnel unaware of group allocation. by personnel unaware of group allocation. (Caregiver , 1989) ); and burden of care (Caregiver Burden Inventory; Novak & Guest, 1989) . Burden Inventory; Novak & Guest, 1989) .
In each of the participating centres, In each of the participating centres, caregivers in the intervention group were caregivers in the intervention group were trained by a team including physicians, trained by a team including physicians, psychologists and therapists to deliver a psychologists and therapists to deliver a programme of reality orientation in paprogramme of reality orientation in patient's own home. They were also provided tient's own home. They were also provided with a manual of instruction on this with a manual of instruction on this therapy and specific schedules for each therapy and specific schedules for each session. During the training meeting, a brief session. During the training meeting, a brief history of reality orientation therapy and history of reality orientation therapy and results obtained by the use of this approach results obtained by the use of this approach in previous studies were presented. Next in previous studies were presented. Next the manual was read and discussed in order the manual was read and discussed in order to answer questions raised by caregivers to answer questions raised by caregivers and to resolve any doubts. In addition, and to resolve any doubts. In addition, caregivers were given a detailed explanacaregivers were given a detailed explanation of how to approach and stimulate the tion of how to approach and stimulate the patients both during the reality orientation patients both during the reality orientation session and informally during the day. session and informally during the day. Finally, a simulated therapy session was Finally, a simulated therapy session was presented. presented.
Caregivers were instructed to provide Caregivers were instructed to provide three orientation sessions per week, for 25 three orientation sessions per week, for 25 consecutive weeks. Each session lasted consecutive weeks. Each session lasted about 30 min and consisted of an orgaabout 30 min and consisted of an organised, intensive cognitive training during nised, intensive cognitive training during which the caregiver gradually presented inwhich the caregiver gradually presented information such as date, time and location. formation such as date, time and location. In the first part of the session attention In the first part of the session attention was directed to personal, time and space was directed to personal, time and space orientation; following this, topics of general orientation; following this, topics of general interest such as historical events and interest such as historical events and famous people, attention, memory and famous people, attention, memory and visuospatial exercises were introduced. visuospatial exercises were introduced. Patients were prompted to give either Patients were prompted to give either spontaneous or cued answers, with the aid spontaneous or cued answers, with the aid of calendars, clocks and notes. Besides the of calendars, clocks and notes. Besides the formal reality orientation sessions, careformal reality orientation sessions, caregivers were also invited to stimulate and givers were also invited to stimulate and involve patients in reality-based communiinvolve patients in reality-based communication two or three times throughout the cation two or three times throughout the day informally, focusing on personal, time day informally, focusing on personal, time and space orientation and discussing news and space orientation and discussing news or topics of general interest. or topics of general interest.
The appropriate local research ethics The appropriate local research ethics committees granted approval. After hearing committees granted approval. After hearing an explanation of the study, patients and an explanation of the study, patients and caregivers who agreed to participate gave caregivers who agreed to participate gave written informed consent. written informed consent.
We calculated that a sample size of 142 We calculated that a sample size of 142 participants allows for detection of a differparticipants allows for detection of a difference of 2 points in MMSE score between ence of 2 points in MMSE score between study groups, with 80% power and at a study groups, with 80% power and at a 0.05 level of type I error. This calculation 0.05 level of type I error. This calculation assumed, on the basis of a previous assumed, on the basis of a previous observation (Metitieri observation (Metitieri et al et al, 2001 ), a , 2001), a common standard deviation of 4 and a common standard deviation of 4 and a 10% withdrawal rate. 10% withdrawal rate.
Statistical analysis Statistical analysis
Differences in baseline characteristics Differences in baseline characteristics between the treatment group and the conbetween the treatment group and the control group in categorical parameters were trol group in categorical parameters were tested using Fisher's exact test. Differences tested using Fisher's exact test. Differences between continuous variables were assessed between continuous variables were assessed by analysis of variance (ANOVA) comparby analysis of variance (ANOVA) comparisons for normally distributed parameters; isons for normally distributed parameters; otherwise, the Kruskal-Wallis test was otherwise, the Kruskal-Wallis test was used. Data were analysed based on intenused. Data were analysed based on intention to treat. Analysis of covariance tion to treat. Analysis of covariance (ANCOVA) was performed to compare (ANCOVA) was performed to compare the change in outcome measures between the change in outcome measures between treatment and control group. Analyses were treatment and control group. Analyses were adjusted for baseline value of the outcome adjusted for baseline value of the outcome measure. In additional analyses, we calcumeasure. In additional analyses, we calculated the number of participants needed to lated the number of participants needed to be treated for 1 patient to achieve one of be treated for 1 patient to achieve one of the following outcomes: an improvement the following outcomes: an improvement of 4 or more points in the ADAS-Cog score, of 4 or more points in the ADAS-Cog score, or any improvement in the ADAS-Cog score or any improvement in the ADAS-Cog score (change in score (change in score 4 40). The number needed 0). The number needed to treat (NNT) was calculated using the to treat (NNT) was calculated using the formula described by Cook & Sackett formula described by Cook & Sackett (1995) . Finally, to explore whether the (1995) . Finally, to explore whether the effect of the intervention on cognitive effect of the intervention on cognitive outcomes (MMSE and ADAS-Cog) difoutcomes (MMSE and ADAS-Cog) differed according to baseline cognitive status, fered according to baseline cognitive status, we repeated ANCOVA comparisons sepawe repeated ANCOVA comparisons separately for patients with baseline MMSE rately for patients with baseline MMSE scores below 20 ( scores below 20 (n n¼60; moderate demen-60; moderate dementia) and those with scores of 20 or over tia) and those with scores of 20 or over ( (n n¼77; mild 77; mild dementia). These analyses dementia). These analyses were adjusted were adjusted for baseline value of the outfor baseline value of the outcome measure. A value of come measure. A value of P P5 50.05 (two-0.05 (twotailed) was considered statistically signifitailed) was considered statistically significant. All analyses cant. All analyses were performed using were performed using the Statistical Package the Statistical Package for the Social for the Social Sciences (SPSS for Windows, version 10.0). Sciences (SPSS for Windows, version 10.0).
RESULTS RESULTS
The mean age of the 156 patients particiThe mean age of the 156 patients participating in the study was 75.8 years pating in the study was 75.8 years (s.d. (s.d.¼7.1); there were 113 (72%) women 7.1); there were 113 (72%) women in the sample and Alzheimer's disease was in the sample and Alzheimer's disease was diagnosed on average 2.0 (s.d. diagnosed on average 2.0 (s.d.¼1.5) years 1.5) years before study entry. Baseline characteristics before study entry. Baseline characteristics of patients and caregivers according to of patients and caregivers according to study group are presented in Table 1 . study group are presented in Table 1 . Seventy of 79 patients in the treatment Seventy of 79 patients in the treatment group and 67 of 77 patients in the control group and 67 of 77 patients in the control group completed the study (Fig. 1) . Only group completed the study (Fig. 1) . Only two patients died during the follow-up two patients died during the follow-up period and four were admitted to period and four were admitted to institutional care. institutional care.
The mean duration of follow-up was The mean duration of follow-up was 25.4 weeks (s.d. 25.4 weeks (s.d.¼5.0). Table 2 compares 5.0). Table 2 compares changes in patient and caregiver outcomes changes in patient and caregiver outcomes between the two study groups, after adjustbetween the two study groups, after adjusting for the baseline value of the outcome ing for the baseline value of the outcome measure examined. Reality orientation measure examined. Reality orientation appeared to have an additive beneficial appeared to have an additive beneficial effect on cognition: in the treatment group effect on cognition: in the treatment group MMSE scores showed a slight improvement MMSE scores showed a slight improvement (0.2 points, s.e. There was no difference between the There was no difference between the two caregiver groups in terms of their detwo caregiver groups in terms of their decline in scores on the HRSD, HRSA, Carecline in scores on the HRSD, HRSA, Caregiver Burden Inventory and SF-36 (Table 2) . giver Burden Inventory and SF-36 (Table 2) . No significant difference between the No significant difference between the groups was observed in Caregiver Burden groups was observed in Caregiver Burden Inventory and SF-36 sub-scales (data not Inventory and SF-36 sub-scales (data not shown). shown).
Overall, 19% of participants in the Overall, 19% of participants in the treatment group and 11% in the control treatment group and 11% in the control group improved by 4 or more points in group improved by 4 or more points in the ADAS-Cog score. When calculating the ADAS-Cog score. When calculating the NNT for this outcome, we found that the NNT for this outcome, we found that 14 people needed to be treated in order 14 people needed to be treated in order for 1 to benefit. Similarly, 45% of particifor 1 to benefit. Similarly, 45% of participants in the treatment group and 36% in pants in the treatment group and 36% in the control group showed an improvement the control group showed an improvement in the ADAS-Cog score (change in score in the ADAS-Cog score (change in score 4 40). In this case, 11 people needed to be 0). In this case, 11 people needed to be treated in order for 1 to benefit. treated in order for 1 to benefit.
In additional analyses we explored the In additional analyses we explored the effect of treatment on cognitive outcomes effect of treatment on cognitive outcomes in patients with moderate dementia in patients with moderate dementia ( (n n¼60) and mild dementia ( 60) and mild dementia (n n¼77). Among 77). Among patients with moderate dementia, treatment patients with moderate dementia, treatment was associated with an improvement in was associated with an improvement in both MMSE score (1.1 points, s.e. both MMSE score (1.1 points, s.e.¼0.7) 0.7) and ADAS-Cog (1.8 points, s.e. and ADAS-Cog (1.8 points, s.e.¼1.2), 1.2), compared with a decline in these measures compared with a decline in these measures observed among patients in the control observed among patients in the control group (MMSE score group (MMSE score 7 70.4, s.e. 0.4, s.e.¼0.6, 0.6, P P¼0.12 0.12 v v. treatment group; ADAS-Cog . treatment group; ADAS-Cog 7 71.8, s.e.
1.8, s.e.¼1.1, 1.1, P P¼0.03 0.03 v v. treatment . treatment group). Among patients with mild demengroup). Among patients with mild dementia, both MMSE and ADAS-Cog scores tia, both MMSE and ADAS-Cog scores declined during the study period, but this declined during the study period, but this change was less marked in the intervention change was less marked in the intervention group than in the control group: MMSE group than in the control group: MMSE score: treatment group score: treatment group 7 70.4 (s.e. 0.4 (s.e.¼0.4), 0. 
DISCUSSION DISCUSSION

Major findings Major findings
Our study shows that among patients with Our study shows that among patients with Alzheimer's disease, a home-based proAlzheimer's disease, a home-based programme of reality orientation therapy gramme of reality orientation therapy provided by the patients' caregivers can provided by the patients' caregivers can enhance the effects of cholinesterase enhance the effects of cholinesterase inhibitors on cognitive function and that inhibitors on cognitive function and that this effect is independent of baseline cognithis effect is independent of baseline cognitive status. This intervention does not seem tive status. This intervention does not seem to modify caregivers' psychological status to modify caregivers' psychological status and quality of life. and quality of life. Our results confirm and extend to the Our results confirm and extend to the long term the beneficial effects of reality long term the beneficial effects of reality orientation on cognitive function reported orientation on cognitive function reported by previous trials of shorter duration by previous trials of shorter duration (Spector (Spector et al et al, 2000 (Spector et al et al, , 2000a (Spector et al et al, a, 2003 , and suggest , 2003), and suggest an additive effect of reality orientation an additive effect of reality orientation when combined with anticholinesterase when combined with anticholinesterase therapy. This effect may be explained therapy. This effect may be explained through cognitive stimulation by carethrough cognitive stimulation by caregivers, which made participants more able givers, which made participants more able to communicate effectively, and to respond to communicate effectively, and to respond to the environment and to other people, by to the environment and to other people, by reinforcing questioning, thinking and reinforcing questioning, thinking and interacting ability. In addition, this cogniinteracting ability. In addition, this cognitive training may have improved patients' tive training may have improved patients' self-esteem through their increased ability self-esteem through their increased ability to retain information and continuous to retain information and continuous encouragement by caregivers (Spector encouragement by caregivers (Spector et al et al, , 2003 (Spector et al et al, , ). 2003 .
The size of the effect of the reality The size of the effect of the reality orientation programme on MMSE score orientation programme on MMSE score (1.3 points) was smaller than we predicted; (1.3 points) was smaller than we predicted; however, Jonsson however, Jonsson et al et al (1999) have shown (1999) have shown that a difference of even 1 point in MMSE that a difference of even 1 point in MMSE score is associated with a substantial reducscore is associated with a substantial reduction in the cost of caring for patients with tion in the cost of caring for patients with dementia. In addition, we failed to show dementia. In addition, we failed to show any significant effect on functional and any significant effect on functional and behavioural changes. Thus, if the benefit behavioural changes. Thus, if the benefit of our intervention is evaluated in the light of our intervention is evaluated in the light of the main objective of psychosocial of the main objective of psychosocial rehabilitation, its value may be limited. rehabilitation, its value may be limited. However, it has been suggested that the However, it has been suggested that the Barthel Index, IADL and behavioural meaBarthel Index, IADL and behavioural measures may have low sensitivity to detect sures may have low sensitivity to detect mild functional and behavioural changes mild functional and behavioural changes related to cognitive stimulation prorelated to cognitive stimulation programmes and that more sensitive outcomes grammes and that more sensitive outcomes (i.e. functional performance measures) (i.e. functional performance measures) might provide a superior method for longimight provide a superior method for longitudinal assessments (Zanetti tudinal assessments (Zanetti et al et al, 1995; , 1995; Onder Onder et al et al, 2002) . In this context, it , 2002). In this context, it should be noted that a recent Cochrane should be noted that a recent Cochrane review concluded that reality orientation review concluded that reality orientation may have a beneficial effect on behaviour may have a beneficial effect on behaviour (Spector (Spector et al et al, 2002 (Spector et al et al, , 2002a , but only one of the ), but only one of the individual trials included demonstrated a individual trials included demonstrated a significant difference in this outcome significant difference in this outcome (Baines . In line with these find-, 1987). In line with these findings, previous studies on cholinesterase ings, previous studies on cholinesterase inhibitor therapy alone showed a lack of inhibitor therapy alone showed a lack of improvement in carers' and patients' funcimprovement in carers' and patients' functional and behavioural outcomes, despite tional and behavioural outcomes, despite a positive effect on cognition (Trinh a positive effect on cognition (Trinh et al et al, , 2003; Courtney 2003; Courtney et al et al, 2004) . , 2004).
Comparison with other Comparison with other reality orientation programmes reality orientation programmes
This is, to our knowledge, the first randomThis is, to our knowledge, the first randomised trial to assess the effectiveness of a ised trial to assess the effectiveness of a home-based reality orientation programme home-based reality orientation programme delivered by caregivers. This study comdelivered by caregivers. This study combines a formal reality orientation approach, bines a formal reality orientation approach, based on lessons given by caregivers on a based on lessons given by caregivers on a regular basis during the week, with an regular basis during the week, with an informal approach, based on repetition of informal approach, based on repetition of orientation information at all times orientation information at all times throughout the day with no fixed schedule. throughout the day with no fixed schedule. Most of the clinical trials published so far Most of the clinical trials published so far evaluated the efficacy of formal therapy evaluated the efficacy of formal therapy given in classrooms where groups of given in classrooms where groups of patients met in specialised centres on a patients met in specialised centres on a regular basis to engage in orientationregular basis to engage in orientationrelated activities. Compared with this latter related activities. Compared with this latter approach, which provides only a 'mass approach, which provides only a 'mass teaching' of generic orientation skills, a teaching' of generic orientation skills, a home-based programme of formal and inhome-based programme of formal and informal reality orientation delivered by careformal reality orientation delivered by caregivers offers the advantage of a more givers offers the advantage of a more individualised treatment (Spector individualised treatment (Spector et al et al, , 2000 (Spector et al et al, , 2000a . In addition, continuous stimulation ). In addition, continuous stimulation and orientation to reality during the day and orientation to reality during the day might be a good way to retain what has might be a good way to retain what has been learned during formal lessons, leading been learned during formal lessons, leading to an increment in the effect of the formal to an increment in the effect of the formal therapy. In this context, it is noteworthy therapy. In this context, it is noteworthy that our home-based programme did not that our home-based programme did not significantly worsen the psychological stasignificantly worsen the psychological status and quality of life of caregivers, suggesttus and quality of life of caregivers, suggesting that the higher burden of care related to ing that the higher burden of care related to the sessions was counterbalanced by the the sessions was counterbalanced by the improvements experienced by patients. improvements experienced by patients.
Effect of reality orientation Effect of reality orientation and baseline cognitive status and baseline cognitive status
We have previously shown that baseline We have previously shown that baseline cognitive function may influence response cognitive function may influence response to reality orientation therapy (Zanetti to reality orientation therapy (Zanetti et al et al, , 2002) . In this study both patients with mild 2002). In this study both patients with mild dementia and those with moderate demendementia and those with moderate dementia significantly benefited from the intertia significantly benefited from the intervention, even if the more severely affected vention, even if the more severely affected patients had a clear gain in terms of MMSE patients had a clear gain in terms of MMSE and ADAS-Cog points, compared with and ADAS-Cog points, compared with stabilisation in scores on these measures stabilisation in scores on these measures observed among the patients with milder observed among the patients with milder dementia. This favourable response in dementia. This favourable response in patients with more severe dementia seems patients with more severe dementia seems in line with the reported effects of antiin line with the reported effects of anticholinesterase treatment. Indeed, Farlow cholinesterase treatment. Indeed, Farlow et al et al (2001) showed that rate of dementia (2001) showed that rate of dementia progression predicts response to cholinesprogression predicts response to cholinesterase inhibitors, and that patients with terase inhibitors, and that patients with more rapidly progressive disease might be more rapidly progressive disease might be particularly likely to benefit from treatment particularly likely to benefit from treatment with these agents. However, we cannot with these agents. However, we cannot exclude the possibility that our findings exclude the possibility that our findings might be explained by a ceiling effect in this might be explained by a ceiling effect in this less compromised group, whose scores in less compromised group, whose scores in the outcome measures were already the outcome measures were already elevated at baseline. elevated at baseline.
Reality orientation Reality orientation and anticholinesterase therapy and anticholinesterase therapy
This is the first trial to evaluate the effect of This is the first trial to evaluate the effect of reality orientation in combination with reality orientation in combination with cholinesterase inhibitor therapy. Particicholinesterase inhibitor therapy. Participants entering the study had already pants entering the study had already received treatment with donepezil for at received treatment with donepezil for at least 3 months, the time required for the least 3 months, the time required for the maximum effect of this drug to be reached maximum effect of this drug to be reached (Feldman (Feldman et al et al, 2001 ). This criterion was , 2001). This criterion was applied to ensure the selection of a group applied to ensure the selection of a group of participants receiving donepezil on a of participants receiving donepezil on a stable basis, to reduce the number of people stable basis, to reduce the number of people leaving treatment because of side-effects, leaving treatment because of side-effects, and to avoid the beneficial response to and to avoid the beneficial response to donepezil observed at the beginning of donepezil observed at the beginning of treatment confounding or hiding the effects treatment confounding or hiding the effects of reality orientation. It is therefore not of reality orientation. It is therefore not surprising that patients in the control group surprising that patients in the control group declined in cognitive outcomes despite declined in cognitive outcomes despite treatment with donepezil, since they had treatment with donepezil, since they had started taking this drug on average 7 started taking this drug on average 7 months before entering the study, by which months before entering the study, by which time the maximum effect of cholinesterase time the maximum effect of cholinesterase inhibitor therapy would be waning. inhibitor therapy would be waning.
Limitations Limitations
A major limitation of this study is that the A major limitation of this study is that the reality orientation programme was admireality orientation programme was administered by caregivers, with no guarantee nistered by caregivers, with no guarantee that patients were receiving the interthat patients were receiving the intervention as intended in the study protocol. vention as intended in the study protocol. However, a poor adherence to study proHowever, a poor adherence to study protocol would have led to a dilution of the tocol would have led to a dilution of the effects, resulting in an underestimation of effects, resulting in an underestimation of the benefits of the intervention. In addition, the benefits of the intervention. In addition, it could be argued that the beneficial effect it could be argued that the beneficial effect of the intervention we observed may be of the intervention we observed may be related to an improvement in social contact related to an improvement in social contact or attention in the intervention group, and or attention in the intervention group, and that the programme should have been comthat the programme should have been compared with other psychosocial approaches. pared with other psychosocial approaches. However, a review by Spector However, a review by Spector et al et al (2000 Spector et al et al ( (2000b showed that there are no differ-) showed that there are no differences in the effect of alternative activities ences in the effect of alternative activities (either no treatment or alternative social (either no treatment or alternative social therapy) offered to control groups during therapy) offered to control groups during trials of reality orientation. Therefore, we trials of reality orientation. Therefore, we concluded from our study that the qualities concluded from our study that the qualities of reality orientation, rather than merely of reality orientation, rather than merely the therapeutic effect of social contact and the therapeutic effect of social contact and attention, may affect patients' outcomes. attention, may affect patients' outcomes.
Another limitation relates to the fact that Another limitation relates to the fact that data on adherence to donepezil treatment data on adherence to donepezil treatment were not collected. During the study period were not collected. During the study period participants might have stopped or changed participants might have stopped or changed their dosage of donepezil, and this could their dosage of donepezil, and this could have influenced their level of cognition. have influenced their level of cognition. Finally, the rate of withdrawal in our study Finally, the rate of withdrawal in our study was 12% (19 of 156 patients), which is was 12% (19 of 156 patients), which is comparable to previous observations with comparable to previous observations with shorter follow-up periods. shorter follow-up periods.
In conclusion, our study shows that a
In conclusion, our study shows that a home-based programme of reality orientahome-based programme of reality orientation provided by caregivers improves cognition provided by caregivers improves cognitive function, enhancing the effect of tive function, enhancing the effect of anticholinesterase treatment alone. Future anticholinesterase treatment alone. Future studies are needed to explore whether the studies are needed to explore whether the benefit of reality orientation may be exbenefit of reality orientation may be extended to physical function and behaviour. tended to physical function and behaviour. The addition of non-pharmacological The addition of non-pharmacological therapy should be recommended in patients therapy should be recommended in patients receiving cholinesterase inhibitors. receiving cholinesterase inhibitors.
Reality orientation for dementia. Reality orientation for dementia. The difference in Mini-Mental State Examination scores between the treatment and control groups, although statistically significant, is lower than predicted for and control groups, although statistically significant, is lower than predicted for sample size calculation. sample size calculation. Despite a positive effect on cognitive function, no significant difference between the treatment and control groups was detected in functional and behavioural the treatment and control groups was detected in functional and behavioural outcomes. outcomes.
